Skip to content
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe
15Aug2025
  • Home
  • About
  • News
  • Subscribe
15Aug2025
Cost Curve NewsCost Curve News
Cost Curve News

Lilly Takes a First Step in ‘Rebalancing’ U.S. and International Prices

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
8 hours ago
Keep Reading
Cost Curve News

The White House View on Pharm-to-Table: ‘It’s Not the Solution in Itself’

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
1 day ago
Keep Reading
Cost Curve News

Three New Drugs, Three Prices, Three Disclosure Approaches

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
2 days ago
Keep Reading
Cost Curve News

A Big Study Found that Semaglutide Users Saw Increased Health Spending. Should We Be Surprised?

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
3 days ago
Keep Reading
Cost Curve News

How MFN Raises the Possibility of a ‘Worst of Both Worlds’ Approach to International Drug Pricing

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
4 days ago
Keep Reading
Cost Curve News

Boehringer Ingelheim’s Appeal to Overturn the IRA on Constitutional Grounds is Dismissed

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
1 week ago
Keep Reading
Cost Curve News

Action On IRA Lawsuits: Appeals Court Rejects the U.S. Chamber Effort on Technical Grounds

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
1 week ago
Keep Reading
Cost Curve News

Pharm-to-Table Commentary on Earnings Calls: So Hot Right Now

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
1 week ago
Keep Reading
Cost Curve News

A Skyrocketing Number of Big City Hospitals Are Qualifying as ‘Administratively Rural’

INFLECTION POINT/ Health Affairs Analysis Shows That Urban Hospitals Are Increasingly Able to Grab Benefits Intended for Rural Facilities All hospitals are not alike. Some are big. Some are small.
1 week ago
Keep Reading
Cost Curve News

A Skyrocketing Number of Big City Hospitals Are Qualifying as ‘Administratively Rural’

Premium Content This content is reserved for premium subscribers of Premium Membership. To Access this and other great posts, consider upgrading to premium. UpgradeLink ConjuctionSign In Powered by beehiiv  
1 week ago
Keep Reading
123

Latest Posts

Lilly Takes a First Step in ‘Rebalancing’ U.S. and International Prices

August 15, 2025

The White House View on Pharm-to-Table: ‘It’s Not the Solution in Itself’

August 14, 2025

Three New Drugs, Three Prices, Three Disclosure Approaches

August 13, 2025

A Big Study Found that Semaglutide Users Saw Increased Health Spending. Should We Be Surprised?

August 12, 2025

How MFN Raises the Possibility of a ‘Worst of Both Worlds’ Approach to International Drug Pricing

August 11, 2025

Popular

Lilly Takes a First Step in ‘Rebalancing’ U.S. and International Prices

The White House View on Pharm-to-Table: ‘It’s Not the Solution in Itself’

Three New Drugs, Three Prices, Three Disclosure Approaches

A Big Study Found that Semaglutide Users Saw Increased Health Spending. Should We Be Surprised?

How MFN Raises the Possibility of a ‘Worst of Both Worlds’ Approach to International Drug Pricing

Boehringer Ingelheim’s Appeal to Overturn the IRA on Constitutional Grounds is Dismissed

Most Viewed
  • CMS Patient-Focused Listening Session Transcripts (2,385)
  • Working Out the Strange Math and Weird Consequences of IRA Inflation Penalties (1,537)
  • New JAMA Research Shows How Much — and How Rapidly — Part D Plans Have Shifted Drug Costs to Consumers (1,358)
  • More IRA Lawsuits Coming, PhRMA Chief Predicts (1,315)
  • Bernie Sanders Wants to Talk to CEOs About US vs ROW Pricing. Bring It On, I Say. (1,313)

Your trusted source for daily updates on drug pricing and policy. Stay informed and ahead of the curve with Cost Curve News.

Latest News

Lilly Takes a First Step in ‘Rebalancing’ U.S. and International Prices

August 15, 2025

The White House View on Pharm-to-Table: ‘It’s Not the Solution in Itself’

August 14, 2025

Subcribe To Newsletter

Subscribe to our newsletter and stay informed about new posts and stay up-to-date on the latest news
Subscribe
© 2025 Cost Curve News | All Rights Reserved
Cost Curve NewsCost Curve News
  • Home
  • About
  • News
  • Subscribe